Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thoraflex Hybrid Post-Market Study

NCT03414866 is registered in ClinicalTrials.gov with Vascutek Ltd. as lead sponsor.

NCT NCT03414866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03414866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thoraflex Hybrid Post-Market Study
Lead sponsor
Vascutek Ltd.
Phase
Observational
Overall status
Active, not recruiting
Start date
May 25, 2018
Completion date
July 31, 2026
Enrollment
182 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

acute aortic dissection, aortic aneurysm, thoracic, aortic dissection, aortic rupture, penetrating aortic ulcer